Being Sick Is Inconvenient: Being the In-Stock Solution Is Very Convenient
There is still plenty of time to act for the Cold & Flu Season of Winter 23/24, which has sustained higher than the national baseline of 2.9% outpatient visits for respiratory illness reported since week 44 of 2023, according to the CDC. With the national average being almost double that of the baseline in week 1 of 2024, further spikes are predicted still to occur before the season is through.
Consumers are clamoring for cold symptom relief
The “tripledemic” as it’s been called (Covid, RSV, & Flu) has caused an influx of consumers to sell out the shelves across the nation of their OTC Cough, Cold & Flu in hopes of warding off symptoms associated with these viruses. We have a solution to respond to the higher-than-usual demand and get your manufacturing of these drugs completed quicker and with more options of convenience for both you and the customer.
Going beyond standard plasticizers, Sorbitol Special provides added benefits to get your softgels out to the market faster, more stable, with more flexibility and for longer.
- The reduced drying times help to produce capsules at greater strength with more speed
- Allows for flexibility in fill and packaging due to its aqueous fill compatibility and leakage prevention
- Developed to provide mechanical stability to endure processing and packaging
- Ensures customer satisfaction through the ability to create product with:
- high-quality shell finish
- formulation consistency
- extended shelf life
- faster patient relief
- convenience/variety in packaging (see more on why packaging matters)
Three differentiated Sorbitol Special blends for formulation flexibility, increased success, reducing costs!
